title: Emerging antiretroviral drug resistance in sub-Saharan Africa: novel affordable technologies are needed to provide resistance testing for individual and public health benefits.
authors.affiliation: aDivision of Medical Virology, Department of Pathology, Stellenbosch University and National Health Laboratory Service Tygerberg, Cape Town, South Africa bDepartments of Pediatrics, Laboratory Medicine and Global Health, University of Washington, and Seattle Children's Research Institute cDepartments of Global Health, Medicine, and Epidemiology, University of Washington, Seattle, Washington, USA dDepartment of Medicine and Center for Infectious Diseases, Stellenbosch University Faculty of Medicine and Health Sciences, Cape Town, South Africa eDepartments of International Health and Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland fDivision of Infectious Diseases, Department of Medicine gDepartment of Epidemiology, Pittsburgh School of Medicine and Graduate School of Public Health, Pittsburgh, Pennsylvania, USA.
authors.forename: Gert U
authors.initials: GU
authors.lastname: van Zyl
authors.forename: Lisa M
authors.initials: LM
authors.lastname: Frenkel
authors.forename: Michael H
authors.initials: MH
authors.lastname: Chung
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Preiser
authors.forename: John W
authors.initials: JW
authors.lastname: Mellors
authors.forename: Jean B
authors.initials: JB
authors.lastname: Nachega
mesh_terms: D017954:Africa South of the Sahara; D044966:Anti-Retroviral Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D024882:Drug Resistance, Viral; D006678:HIV / Q000187:drug effects* / Q000302:isolation & purification*; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology*; D006801:Humans; D015994:Incidence; D008826:Microbial Sensitivity Tests / Q000379:methods / Q000706:statistics & numerical data
chemical_list: D044966:Anti-Retroviral Agents